Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
22.82
+0.88 (4.01%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $895.5 million as of October 19, 2026. It is the 10,744th most valuable company in the world and the 2,291st biggest in the United States. Its market cap has increased by 443.96% in one year.
Market Cap
895.50M
Enterprise Value
675.07M
1-Year Change
443.96%
Global Rank
Country Rank
#2,291 United States
Category
ChartMarket Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $895.50M, an increase of 69.38%. That is a compound annual growth rate of 21.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 895.50M | 61.94% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 891.28M |
| SL Science Holding | 872.51M |
| Rigel Pharmaceuticals | 858.71M |
| Jade Biosciences | 856.66M |
| Aktis Oncology | 837.63M |
| Arbutus Biopharma | 834.92M |
| Cullinan Therapeutics | 832.11M |
| Monte Rosa Therapeutics | 830.95M |